K J Anderson1, J M Harten, M G Booth, J Kinsella. 1. Glasgow Royal Infirmary, University of Glasgow, Department of Anaesthesia, Glasgow, UK. keithanderson@doctors.net.uk
Abstract
BACKGROUND AND OBJECTIVE: Increased inspired oxygen fractions (FiO2) have significant haemodynamic effects in awake volunteers. We sought to establish whether these effects are also present in anaesthetized patients. METHODS: We prospectively studied 30 ASA I-II patients, 15 in each of a propofol and sevoflurane group. Their haemodynamic responses, awake and anaesthetized, when the FiO2 was changed between 0.3 and 1.0 were measured with a non-invasive transthoracic bio-impedance monitor. RESULTS: While preoxygenating awake patients in both groups the FiO2 was increased from 0.21 to 1.0. This reduced the mean cardiac index (3.38 +/- 0.5 to 3.03 +/- 0.5 L min(-1) m(-2); P < 0.001); reduced the heart rate (HR) (68.1 +/- 10.4 to 62.8 +/- 9.4 beats per minute (bpm); P < 0.001); and reduced the stroke index (50.4 +/- 9.6 to 48.5 +/- 8.6; P = 0.02). It increased the systemic vascular resistance index (2060 +/- 319 to 2220 +/- 382 dyn s(-1) cm(-5) m(-2); P = 0.002); but did not change mean arterial pressure. In the anaesthetized patients, when decreasing the FiO2 from 1.0 to 0.3, mean cardiac index (L min(-1) m(-2) increased (3.06 +/- 0.57 to 3.25 +/- 0.56, P = 0.008 for sevoflurane; 2.76 +/- 0.46 to 2.89 +/- 0.42, P = 0.002 for propofol). The mean HR (bpm) increased (65.1 +/- 7.8 to 69.1 +/- 7.5, P < 0.001 for sevoflurane; 67.5 +/- 11.8 to 72.7 +/- 11.6, P = 0.001 for propofol). The mean systemic vascular resistance (dyn s(-1) cm(-5) m(-2)) decreased (1883 +/- 329 to 1735 +/- 388, P = 0.008 for sevoflurane; 2015 +/- 369 to 1771 +/- 259, P = 0.003 for propofol). Mean arterial pressure (mmHg) decreased (74.8 +/- 8.7 to 71.4 +/- 8.7, P < 0.001 for sevoflurane; 72.1 +/- 8 to 66.5 +/- 6.8, P = 0.002 for propofol). CONCLUSION: O2 has haemodynamic effects in awake and anaesthetized patients. These effects were of overall similar magnitude for patients anaesthetized with propofol and sevoflurane.
BACKGROUND AND OBJECTIVE: Increased inspired oxygen fractions (FiO2) have significant haemodynamic effects in awake volunteers. We sought to establish whether these effects are also present in anaesthetized patients. METHODS: We prospectively studied 30 ASA I-II patients, 15 in each of a propofol and sevoflurane group. Their haemodynamic responses, awake and anaesthetized, when the FiO2 was changed between 0.3 and 1.0 were measured with a non-invasive transthoracic bio-impedance monitor. RESULTS: While preoxygenating awake patients in both groups the FiO2 was increased from 0.21 to 1.0. This reduced the mean cardiac index (3.38 +/- 0.5 to 3.03 +/- 0.5 L min(-1) m(-2); P < 0.001); reduced the heart rate (HR) (68.1 +/- 10.4 to 62.8 +/- 9.4 beats per minute (bpm); P < 0.001); and reduced the stroke index (50.4 +/- 9.6 to 48.5 +/- 8.6; P = 0.02). It increased the systemic vascular resistance index (2060 +/- 319 to 2220 +/- 382 dyn s(-1) cm(-5) m(-2); P = 0.002); but did not change mean arterial pressure. In the anaesthetized patients, when decreasing the FiO2 from 1.0 to 0.3, mean cardiac index (L min(-1) m(-2) increased (3.06 +/- 0.57 to 3.25 +/- 0.56, P = 0.008 for sevoflurane; 2.76 +/- 0.46 to 2.89 +/- 0.42, P = 0.002 for propofol). The mean HR (bpm) increased (65.1 +/- 7.8 to 69.1 +/- 7.5, P < 0.001 for sevoflurane; 67.5 +/- 11.8 to 72.7 +/- 11.6, P = 0.001 for propofol). The mean systemic vascular resistance (dyn s(-1) cm(-5) m(-2)) decreased (1883 +/- 329 to 1735 +/- 388, P = 0.008 for sevoflurane; 2015 +/- 369 to 1771 +/- 259, P = 0.003 for propofol). Mean arterial pressure (mmHg) decreased (74.8 +/- 8.7 to 71.4 +/- 8.7, P < 0.001 for sevoflurane; 72.1 +/- 8 to 66.5 +/- 6.8, P = 0.002 for propofol). CONCLUSION:O2 has haemodynamic effects in awake and anaesthetized patients. These effects were of overall similar magnitude for patients anaesthetized with propofol and sevoflurane.
Authors: Jorn Fierstra; Matthew Machina; Anne Battisti-Charbonney; James Duffin; Joseph Arnold Fisher; Leonid Minkovich Journal: Intensive Care Med Date: 2011-06-07 Impact factor: 17.440
Authors: Jorn Fierstra; Jeff D Winter; Matthew Machina; Jelena Lukovic; James Duffin; Andrea Kassner; Joseph A Fisher Journal: J Clin Monit Comput Date: 2012-10-26 Impact factor: 2.502
Authors: John A E Hubbell; Turi K Aarnes; Richard M Bednarski; Phillip Lerche; William W Muir Journal: BMC Vet Res Date: 2011-06-03 Impact factor: 2.741
Authors: B Smit; Y M Smulders; M C de Waard; H M Oudemans-van Straaten; A R J Girbes; E C Eringa; A M E Spoelstra-de Man Journal: PLoS One Date: 2017-08-10 Impact factor: 3.240
Authors: Bob Smit; Yvo M Smulders; Etto C Eringa; Harry P M M Gelissen; Armand R J Girbes; Harm-Jan S de Grooth; Hans H M Schotman; Peter G Scheffer; Heleen M Oudemans-van Straaten; Angelique M E Spoelstra-de Man Journal: Microcirculation Date: 2018-02 Impact factor: 2.628